Witness Credibility Analysis
California Public Utilities Commission Stretches Out the Reimbursement Period for Data Center’s Energization Costs to Reduce Ratepayer Risk
November 19, 2025 Energy Law The search for a reliable source of electricity to power data centers has led developers to explore self-g...
China Monthly Data Protection Update – November 2025
This monthly report outlines key developments in China’s data protection sector for November. The following events merit special attent...
FDA Accepts Sanofi and Regeneron’s Dupixent sBLA for Priority Review
On November 11, 2025, Sanofi and Regeneron announced that the FDA accepted for priority review its supplemental biologics license appli...
India Notifies Final Rules for Digital Data Protection Act
After legal review following the expected notification date at the end of September, India's government has notified the Digital Person...
Canada’s Competition Bureau Offers Practical Guidance on Algorithmic Pricing
On November 10, 2025, Canada's Competition Bureau ("Bureau") discontinued its civial investigation into the use of algorithmic pricing ...
Q4 Bacon & Business Follow-Up: Harnessing Intrapreneurship & Entrepreneurship for Innovation & Growth
Successful businesses face a critical challenge: How do you protect today's profits while building tomorrow's innovations? Our November...
Director Squires Designates Ex Parte Desjardins Decision as Precedential
On November 4, 2025, Director of the U.S. Patent and Trademark Office, John Squires, designated the Ex Parte Desjardins decision of Sep...
[Video] Key Discovery Points: If You’re Planning to Submit GenAI Deepfake Evidence, Make Sure It’s Believable
In this Key Discovery Points video, Brett Burney of Nextpoint and Doug Austin of eDiscovery Today discuss Mendones v. Cushman & Wak...
ECON Report On Impact Of AI On The Financial Sector
The European Parliament's Committee on Economic and Monetary Affairs (ECON) has adopted its final report on the impact of AI on the fin...
Amgen Files BPCIA Complaint Against Alkem Related to Denosumab Biosimilar
On November 14, 2025, Amgen, Inc. (“Amgen”) launched another BPCIA denosumab litigation when it filed a complaint in the U.S. District ...